Rose Crane, CEO of Melanoma Diagnostics Provider, MELA Sciences, to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW1190AM

[Marketwired] – MELA Sciences, Inc. , developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in melanoma diagnosis, announced that its CEO Rose Crane will be interviewed live today … more

View todays social media effects on MELA

View the latest stocks trending across Twitter. Click to view dashboard

See who MELA is hiring next, click here to view